Lista de obras - Bruce L. Innis - Dominio Público Uruguay

A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine

artículo científico publicado en 2020

A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine

scientific article published on 31 July 2020

A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico

artículo científico publicado en 2015

A Phase III Evaluation of Immunogenicity and Safety of Two Trivalent Inactivated Seasonal Influenza Vaccines in US Children

article

A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice

artículo científico publicado en 2016

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

artículo científico publicado en 2020

A historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine.

artículo científico publicado en 2014

A model international partnership for community-based research on vaccine-preventable diseases: the Kamphaeng Phet-AFRIMS Virology Research Unit (KAVRU).

artículo científico

A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adults

artículo científico publicado en 2012

A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.

artículo científico

A putative cellular receptor for dengue viruses

artículo científico publicado en 1997

A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age

artículo científico publicado en 2013

A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.

artículo científico publicado en 2017

A short report on clinical evaluation of RIX4414: highlights of world-wide development

artículo científico publicado en 2005

A short report on highlights of world-wide development of RIX4414: a Latin American experience

artículo científico publicado en 2005

AS03-adjuvanted H7N1 detergent-split virion vaccine is highly immunogenic in unprimed mice and induces cross-reactive antibodies to emerged H7N9 and additional H7 subtypes

artículo científico publicado en 2015

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

artículo científico publicado en 2013

AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial.

artículo científico publicado en 2014

An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques

artículo científico publicado en 2015

An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model

artículo científico publicado en 2005

Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2.

artículo científico publicado en 1995

Antibody-enhanced binding of dengue-2 virus to human platelets.

artículo científico publicado en 1995

Antiserum generated by DNA vaccine binds to hepatitis E virus (HEV) as determined by PCR and immune electron microscopy (IEM): application for HEV detection by affinity-capture RT-PCR.

artículo científico publicado en 1999

Applications of polymerase chain reaction for identification of dengue viruses isolated from patient sera

artículo científico publicado en 1993

Association of hepatitis E virus with an outbreak of hepatitis in Pakistan: serologic responses and pattern of virus excretion

artículo científico publicado en 1992

Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example

artículo científico publicado en 2009

Characterization of a genetic variant of human hepatitis A virus

artículo científico publicado en 1992

Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice

article

Clinical and immunological risk factors for severe disease in Japanese encephalitis

artículo científico publicado en 2002

Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy

artículo científico publicado en 1985

Comment on "CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy".

artículo científico publicado en 2014

Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine

artículo científico publicado en 2005

Cost-effectiveness of universal childhood hepatitis A vaccination in Chile

article

Dengue infection complicated by severe hemorrhage and vertical transmission in a parturient woman.

artículo científico publicado en 1994

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

artículo científico publicado en 2000

Early Immune Activation in Acute Dengue Illness Is Related to Development of Plasma Leakage and Disease Severity

article

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

artículo científico publicado en 2004

Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial.

artículo científico

Evaluation of dengue virus strains for human challenge studies.

artículo científico publicado en 2014

Evaluation of potential immunogenicity differences between Pandemrix™ and Arepanrix™.

artículo científico publicado en 2016

Evidence that rodents are a reservoir of hepatitis E virus for humans in Nepal

artículo científico publicado en 2002

Evidence that rodents are a reservoir of hepatitis E virus for humans in Nepal

article

Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.

artículo científico publicado en 2015

Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines

artículo científico publicado en 2012

Falciparum malaria modulates viremia in chronic hepatitis B virus infection

artículo científico publicado en 1992

Genetic characterization of early isolates of Japanese encephalitis virus: genotype II has been circulating since at least 1951.

artículo científico publicado en 2009

HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais.

artículo científico publicado en 2002

Hepatitis A in the US Army: epidemiology and vaccine development

artículo científico publicado el 1 de enero de 1992

Hepatitis B virus infection in Thai children

artículo científico publicado en 2000

Hepatitis E antibody kinetics in Nepalese patients

article

Hepatitis E virus DNA vaccine elicits immunologic memory in mice

artículo científico publicado en 2001

Hepatitis E virus in Nepal: similarities with the Burmese and Indian variants

artículo científico publicado en 1997

Hepatitis E virus: complete genome sequence and phylogenetic analysis of a Nepali isolate

artículo científico publicado en 1998

Identification of hepatitis E virus in clinical specimens: amplification of hydroxyapatite-purified virus RNA and restriction endonuclease analysis

artículo científico publicado en 1997

Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012-2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial

artículo científico publicado en 2014

Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults

artículo científico publicado en 2016

Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial.

artículo científico publicado en 2015

Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation.

artículo científico publicado en 2014

Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65years of age and older: A phase II, observer-blind, randomized, controlled trial.

artículo científico publicado en 2017

Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in healthy adults: A phase I/II, observer-blind, randomized, controlled trial

artículo científico publicado en 2017

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children

artículo científico publicado en 2013

Immunogenicity and safety of inactivated quadrivalent and trivalent influenza vaccines in children 18-47 months of age.

artículo científico publicado en 2014

Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age.

artículo científico publicado en 2012

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

scientific article published on 17 October 2019

Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial

artículo científico publicado en 2014

Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines

artículo científico publicado en 2014

Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate

artículo científico publicado en 2011

Large epidemic of adenovirus type 4 infection among military trainees: epidemiological, clinical, and laboratory studies.

artículo científico publicado en 2002

Mechanisms of dengue virus-induced bone marrow suppression

artículo científico publicado en 1995

Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts

scientific article published on 06 December 2019

Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults

artículo científico publicado en 2009

Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus

artículo científico publicado en 2000

Protection against hepatitis A by an inactivated vaccine

scientific article published in The Journal of the American Medical Association

Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial

artículo científico

Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.

artículo científico publicado en 2006

Relative efficacy of AS03-adjuvanted pandemic influenza A(H1N1) vaccine in children: results of a controlled, randomized efficacy trial.

artículo científico publicado en 2014

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

artículo científico publicado en 2006

Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 Months.

artículo científico publicado en 2014

Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults

artículo científico publicado en 2010

Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: pooled analysis of 28 clinical trials.

artículo científico publicado en 2014

Seeking help: B cells adapting to flu variability

artículo científico publicado en 2014

Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers

artículo científico publicado en 1996

The Declining Transmission of Hepatitis A in Thailand ⬇️

artículo científico publicado el 1 de mayo de 1991

Vaccine for Prevention of Influenza in Children

artículo científico publicado en 2014

Vaccine for prevention of mild and moderate-to-severe influenza in children

artículo científico publicado en 2013

Viremia, Fecal Shedding, and IgM and IgG Responses in Patients with Hepatitis E

article

Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuation

artículo científico publicado en 1988

Virus-like particles in the liver of a patient with fulminant hepatitis and antibody to hepatitis E virus

artículo científico publicado en 1990

Lista de obras de Bruce L. Innis

A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine

A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine

A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico

A Phase III Evaluation of Immunogenicity and Safety of Two Trivalent Inactivated Seasonal Influenza Vaccines in US Children

A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

A historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine.

A model international partnership for community-based research on vaccine-preventable diseases: the Kamphaeng Phet-AFRIMS Virology Research Unit (KAVRU).

A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adults

A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.

A putative cellular receptor for dengue viruses

A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age

A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.

A short report on clinical evaluation of RIX4414: highlights of world-wide development

A short report on highlights of world-wide development of RIX4414: a Latin American experience

AS03-adjuvanted H7N1 detergent-split virion vaccine is highly immunogenic in unprimed mice and induces cross-reactive antibodies to emerged H7N9 and additional H7 subtypes

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial.

An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques

An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model

Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2.

Antibody-enhanced binding of dengue-2 virus to human platelets.

Antiserum generated by DNA vaccine binds to hepatitis E virus (HEV) as determined by PCR and immune electron microscopy (IEM): application for HEV detection by affinity-capture RT-PCR.

Applications of polymerase chain reaction for identification of dengue viruses isolated from patient sera

Association of hepatitis E virus with an outbreak of hepatitis in Pakistan: serologic responses and pattern of virus excretion

Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example

Characterization of a genetic variant of human hepatitis A virus

Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice

Clinical and immunological risk factors for severe disease in Japanese encephalitis

Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy

Comment on "CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy".

Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine

Cost-effectiveness of universal childhood hepatitis A vaccination in Chile

Dengue infection complicated by severe hemorrhage and vertical transmission in a parturient woman.

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

Early Immune Activation in Acute Dengue Illness Is Related to Development of Plasma Leakage and Disease Severity

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial.

Evaluation of dengue virus strains for human challenge studies.

Evaluation of potential immunogenicity differences between Pandemrix™ and Arepanrix™.

Evidence that rodents are a reservoir of hepatitis E virus for humans in Nepal

Evidence that rodents are a reservoir of hepatitis E virus for humans in Nepal

Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.

Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines

Falciparum malaria modulates viremia in chronic hepatitis B virus infection

Genetic characterization of early isolates of Japanese encephalitis virus: genotype II has been circulating since at least 1951.

HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais.

Hepatitis A in the US Army: epidemiology and vaccine development

Hepatitis B virus infection in Thai children

Hepatitis E antibody kinetics in Nepalese patients

Hepatitis E virus DNA vaccine elicits immunologic memory in mice

Hepatitis E virus in Nepal: similarities with the Burmese and Indian variants

Hepatitis E virus: complete genome sequence and phylogenetic analysis of a Nepali isolate

Identification of hepatitis E virus in clinical specimens: amplification of hydroxyapatite-purified virus RNA and restriction endonuclease analysis

Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012-2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial

Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults

Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial.

Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation.

Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65years of age and older: A phase II, observer-blind, randomized, controlled trial.

Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in healthy adults: A phase I/II, observer-blind, randomized, controlled trial

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children

Immunogenicity and safety of inactivated quadrivalent and trivalent influenza vaccines in children 18-47 months of age.

Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age.

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial

Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines

Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate

Large epidemic of adenovirus type 4 infection among military trainees: epidemiological, clinical, and laboratory studies.

Mechanisms of dengue virus-induced bone marrow suppression

Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts

Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults

Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus

Protection against hepatitis A by an inactivated vaccine

Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial

Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.

Relative efficacy of AS03-adjuvanted pandemic influenza A(H1N1) vaccine in children: results of a controlled, randomized efficacy trial.

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 Months.

Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults